Vera Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 59.8% | 59.8% | -97.9% |
| FY2021 | -46.9% | -43.8% | -38.9% |
| FY2022 | -115.8% | -87.6% | -67.8% |
| FY2023 | -94.4% | -63.3% | -54.7% |
| FY2024 | -26.4% | -24.2% | -23.2% |
| FY2025 | -49.6% | -44.1% | -40.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 59.8% | 59.8% | -97.9% |
| FY2021 | -46.9% | -43.8% | -38.9% |
| FY2022 | -115.8% | -87.6% | -67.8% |
| FY2023 | -94.4% | -63.3% | -54.7% |
| FY2024 | -26.4% | -24.2% | -23.2% |
| FY2025 | -49.6% | -44.1% | -40.8% |